press center press release

Probi AB listed at Stockholm Stock Exchange


Probi AB listed at Stockholm Stock Exchange As of today, the biotechnology company Probi AB is listed on the Stockholm Stock Exchanges O list. Probi is a biotech company that develops and patents probiotic bacteria for use in nutritional products. The probiotic bacteria are licensed to players within functional food, dietary supplements and clinical nutrition. Probi was founded in 1991 and has its headoffice in Lund, Sweden. We warmly welcome Probi to Stockholm Stock Exchange, says Henrik Paulsson, acting President of Stockholm Stock Exchange. Per Bengtsson, CEO of Probi AB, comments: The listing on the Stockholm Stock Exchanges O list will form the basis for a sound liquidity in the Probi-share. We also believe that the listing will strengthen the confidence in Probi among our customers and partners. Photos from the welcoming ceremony and a web cast interview with Probis CEO Per Bengtsson, are available on under Corporate actions, Changes in listed companies and listings. Information about the industry classification and similar details is also available on under Corporate actions and Press Releases and Exchange Notices/Search/Equity related information. For more information, please contact: Per Bengtsson, CEO, Probi AB, +46 734 47 41 28 Per-Ola Forsberg,, CFO, Probi AB, +46 733 448384 Frank Teneberg, Issuer Sales, Stockholm Stock Exchange, +46 8 405 6954 Annika Molander, Vice President Communications, OMX Exchanges Stockholm, +46 8 405 6610 About OMX Exchanges | OMX is a leading partner for more efficient securities transactions. OMX consists of two divisions: OMX Technology and OMX Exchanges. Through the OMX Exchanges division, OMX owns and operates the equity and derivatives exchanges in Stockholm, Helsinki, Tallinn, Riga and Vilnius as well as the central securities depositories in Estonia and Latvia. Through OMX Exchanges, OMX offers access to 80 percent of the Nordic and Baltic Securities market. For more information please visit PDF

In This Story

Nasdaq Press Center

Read the latest press releases, request a press kit, and get in touch with our press team.

learn more